Newregen IncOTC Pink - Current Information:NREG
- LAST PRICE0.0130
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0090/ 100
- Ask / Lots0.0130/ 100
- Open / Previous Close0.0000 / 0.0130
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Newregen Inc | 1.6M | 0.0x | --- |
PTS Inc | 1.9M | 0.0x | --- |
Cyberdyne Inc | 179.3M | -31.9x | --- |
avVaa World Health Care Products Inc | 1.1M | 36.7x | --- |
Mitesco Inc | 2.5M | -0.2x | --- |
Modern Mobility Aids Inc | 2.5M | -0.6x | --- |
Company Information
Newregen, Inc. provides anti-aging and regenerative medical treatments. It operates two brick and mortar and one Affiliated clinic. These are located in Atlanta, GA, Ft Lauderdale, FL and Tupelo MS. Its treatments have shown outcomes in autoimmune, inflammatory, neurological, and orthopedic conditions, injuries and other chronic pains. It is also focused on expanding its operations in FL and GA by adding additional affiliate clinics. It offers various services, including hormone replacement therapy, allograft suspension (stem cell) therapy, longevity, immunity, testosterone replacement therapy, weight management and others. It also offers multiple forms of hormone therapy, peptide therapy, cellular therapy, and other wellness therapies that complement their core services. The hormone replacement therapy treats a range of naturally occurring symptoms, including weight gain, increased body fat/decreased muscle mass, low energy, hair loss and others. Its subsidiary is ReGenMD, Inc.
Contact Information
- Headquarters
- One Glenlake Parkway #650ATLANTA, GA, United States 30328
- Phone
- 855-290-3195
- Fax
- ---
Executives
- President, Chief Executive Officer, Chief Financial Officer, Director
- Stephen Shepherd
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6M |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | 124.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 6.38 |
EPS | --- |
Book Value | $0.00 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
